E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedMachine draft
Standard · 3 min
Distinguishing features of long COVID identified through immune profiling.
Klein, Jon, Wood, Jamie, Jaycox, Jillian R et al. · Nature · 2023 · DOI
Quick Summary
Researchers studied 275 people with and without long COVID to understand what happens in the immune system. They found that people with long COVID have different patterns of immune cells and antibodies, including stronger responses to past viral infections like Epstein-Barr virus, and lower levels of the stress hormone cortisol. Using computer analysis, they identified specific immune markers that could help identify who has long COVID.
Why It Matters
This study provides objective, measurable immune biomarkers associated with long COVID, which could accelerate diagnosis and pathophysiologic understanding relevant to post-viral syndromes broadly. For ME/CFS patients specifically, identifying immune dysfunction patterns offers potential for developing targeted treatments and distinguishing long COVID from other post-infectious fatigue syndromes.
Observed Findings
Altered circulating myeloid and lymphocyte populations in long COVID participants compared to matched controls
Exaggerated humoral (antibody) responses against SARS-CoV-2 in long COVID group
Elevated antibody responses against non-SARS-CoV-2 viral pathogens, particularly Epstein-Barr virus, in long COVID participants
Lower cortisol levels in individuals with long COVID relative to controls
Machine learning models identified specific immune features most strongly associated with long COVID status
Inferred Conclusions
Dysregulated immune responses, including altered lymphoid and myeloid compartments and exaggerated viral-specific antibody production, are associated with long COVID
Cross-reactive humoral responses (elevated EBV and other non-SARS-CoV-2 antibodies) may indicate sustained immune activation or viral reactivation in long COVID
Altered neuroendocrine function, reflected in reduced cortisol, may contribute to immunologic dysfunction in long COVID
Multidimensional immune profiling can identify biological signatures predictive of long COVID status
Remaining Questions
Do the identified immune abnormalities directly cause long COVID symptoms, or are they secondary consequences of other pathogenic processes?
What This Study Does Not Prove
This study does not establish whether the observed immune abnormalities cause long COVID symptoms or are merely epiphenomena; it does not prove these biomarkers will be clinically useful for diagnosis in individual patients; and the cross-sectional design cannot determine whether immune dysfunction precedes, accompanies, or follows symptom development. Additionally, findings from SARS-CoV-2 infection may not fully translate to other post-viral syndromes including ME/CFS.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →